Research

The extracellular matrix that surrounds cells plays a role in the development of insulin resistance. Read More

A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial. Read More

One of the most formidable weapons in a cancer’s arsenal is the ability to spread to other organs. Read More

Walk into ophthalmologist Anita Agarwal’s office at the Vanderbilt Eye Institute and there is something remarkably different about the décor. Read More

Vanderbilt University Medical Center has been selected as one of three sites to share a three-year, $1.3 million grant from the National Institutes of Health (NIH) to explore the potential therapeutic properties of manganese, a chemical element and biologically essential trace mineral, in treating Restless Legs Syndrome (RLS). Read More

More than 15 million women in the United States are impacted by stress urinary incontinence (SUI) at a cost of nearly $20 billion a year to treat. Read More

Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease. Read More

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response. Read More

Vanderbilt investigators have used two types of neuroimaging to establish a “map” of connections for a brain region important in anxiety and addiction. Read More

Vanderbilt University law professor Rebecca Haw told a U.S. House subcommittee that the power of state licensing boards should be trimmed to the point where competition can again take hold. Read More

Vanderbilt physicist John Wikswo reported significant progress toward creating “homo minutus” – a human-on-a-chip that can be used to test drugs and toxins – on Mar. 26 at the Society of Toxicology meeting in Phoenix. Read More

A multidisciplinary team of microbiome researchers at Vanderbilt University is shedding light on necrotizing enterocolitis (NEC), a disease of prematurity that kills hundreds of babies and costs the U.S. health care system an estimated $5 billion a year. Read More

Patient-centered outcomes research is the focus of a $3.3 million, five-year, institutional K12 training grant awarded to Vanderbilt University Medical Center by the Agency for Healthcare Research and Quality (AHRQ). Read More

A gene on chromosome 8 — in a region of the genome linked to risk for many types of cancer — is particularly associated with prostate cancer susceptibility, Vanderbilt University researchers have found. Read More

Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia. Read More

By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer. Read More

Vanderbilt psychologists show it is possible to selectively manipulate our ability to learn through the application of a mild electrical current to the brain, and that this effect can be enhanced or depressed depending on the direction of the current. Read More

Experts from Vanderbilt University’s Peabody College of education and human development are available to discuss issues related to the reauthorization of the Higher Education Act in 2014. Read More

Researchers at Vanderbilt have been able to alter mouse behavior by silencing gene expression in interneurons, distinct populations of nerve cells that are the main regulators of brain circuits. Read More

A compound identified at Vanderbilt has therapeutic potential in protecting the kidney filter barrier. Read More